- Investing Ideas
- Canadian Pharmaceuticals & Biotech Top Stock Picks from Analysts
Canadian Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
20
Companies which are more than 50% undervalued based on analyst price target.
20 companies
Green Thumb Industries
Market Cap: CA$2.2b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$9.91
7D
-6.1%
1Y
24.0%
Verano Holdings
Market Cap: CA$579.4m
Engages in the cannabis business in the United States.
VRNO
CA$7.95
7D
-2.8%
1Y
101.3%
Eupraxia Pharmaceuticals
Market Cap: CA$576.8m
A clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need.
EPRX
CA$8.99
7D
0.9%
1Y
30.9%
Canopy Growth
Market Cap: CA$553.0m
Engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally.
WEED
CA$1.32
7D
-1.5%
1Y
-21.9%
Cresco Labs
Market Cap: CA$458.7m
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.
CL
CA$1.00
7D
-9.1%
1Y
20.5%
Spectral Medical
Market Cap: CA$410.8m
Focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally.
EDT
CA$1.40
7D
2.9%
1Y
75.0%
TerrAscend
Market Cap: CA$294.7m
TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.
TSND
CA$0.77
7D
-9.4%
1Y
54.0%
High Tide
Market Cap: CA$268.9m
Engages in the cannabis retail business in Canada, the United States, and internationally.
HITI
CA$3.11
7D
2.0%
1Y
-4.9%
Aurora Cannabis
Market Cap: CA$227.3m
Engages in the production, distribution, and sale of cannabis products in Canada and internationally.
ACB
CA$3.78
7D
0.5%
1Y
-45.0%
Cardiol Therapeutics
Market Cap: CA$201.7m
A clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.
CRDL
CA$1.77
7D
8.6%
1Y
-5.9%
Organigram Global
Market Cap: CA$183.0m
Engages in the production and sale of cannabis and cannabis-derived products in Canada.
OGI
CA$1.32
7D
5.6%
1Y
-37.4%
HLS Therapeutics
Market Cap: CA$128.5m
A specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders and cardiovascular disease in Canada, the United States, and internationally.
HLS
CA$4.20
7D
1.4%
1Y
-14.5%
Decibel Cannabis
Market Cap: CA$63.5m
An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.
DB
CA$0.10
7D
-8.7%
1Y
5.0%
Vext Science
Market Cap: CA$63.2m
Through its subsidiaries, engages in integrated cannabis operations in the United States.
VEXT
CA$0.25
7D
0%
1Y
47.1%
Planet 13 Holdings
Market Cap: CA$62.0m
Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.
PLTH
CA$0.17
7D
-10.5%
1Y
-37.0%
Sernova Biotherapeutics
Market Cap: CA$41.5m
Operates as a clinical-stage biotechnology company in Canada.
SVA
CA$0.11
7D
-4.3%
1Y
-37.1%
Optimi Health
Market Cap: CA$37.9m
Operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada.
OPTI
CA$6.56
7D
13.1%
1Y
32.5%
Medicenna Therapeutics
Market Cap: CA$32.3m
A clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases.
MDNA
CA$0.35
7D
-4.1%
1Y
-56.8%
Rubicon Organics
Market Cap: CA$30.4m
Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.
ROMJ
CA$0.46
7D
2.2%
1Y
4.5%
Delivra Health Brands
Market Cap: CA$3.1m
Through its subsidiaries, engages in the health and wellness consumer packaged goods business worldwide.
DHB
CA$0.10
7D
0%
1Y
-54.5%